Migrevention OÜ
PrivateLast Round
Grant
Feb 1, 2023
Total Funding Raised
$1.03M
Company Overview
Migrevention OÜ operates in Healthcare & Life Sciences and is based in Tallinn. Its latest recorded funding round was a Grant round in February 2023.
Migrevention OÜ is a digital health company that provides a software-based medical device platform for the diagnosis, monitoring, and treatment of migraine and chronic headache patients.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Medical Devices, Patient Engagement, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Freemium
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Migrevention OÜ Comparables
Compare Migrevention OÜ with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cascador Health | 79% | |
| Neura Health | 77% | |
| Curelator, LLC | 76% |
For institutional investors. Book with your work email.
Migrevention OÜ Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 1, 2023 | ||||
| Pre Seed | Jan 3, 2022 | ||||
| Grant | Jun 1, 2021 | ||||
| Grant | Jun 1, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Migrevention OÜ Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Regional Development Fund | Grant |
| Health Founders | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 1, 2023
Secured $159K in grant funding.
- Jun 1, 2020
$85K grant from European Regional Development Fund.
For institutional investors. Book with your work email.
Migrevention OÜ Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Migrevention OÜ's valuation, stock price, and market status.
Is Migrevention OÜ a public or private company?
Migrevention OÜ is a private company.
What is the current stock price of Migrevention OÜ?
Migrevention OÜ is a private company, so its shares have no public market price. Caplight tracks Migrevention OÜ's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Migrevention OÜ worth (valuation)?
Valuation information for Migrevention OÜ is not publicly available.
Can I buy Migrevention OÜ stock?
Migrevention OÜ shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Migrevention OÜ's last funding round?
Migrevention OÜ's most recent funding round was Grant on February 1, 2023.
Who are the main investors in Migrevention OÜ?
Key investors in Migrevention OÜ include European Regional Development Fund, Health Founders.
Will Migrevention OÜ IPO soon?
No public IPO plans have been announced for Migrevention OÜ.
How can I track Migrevention OÜ secondary market activity?
Caplight tracks bids, offers, and trades in Migrevention OÜ's shares on secondary markets.